Shares of Apyx Medical Corp (APYX) are trading -5% lower at a price of $5.88 at the time of this writing. While the Health Care sector is having a slightly somber day in general, the company is trailing behind it's peers.

Apyx Medical Corp has been trading between a 52-week high of $17.5 and a 52-week low of $3.01. The stock has a market cap of $203 Million.

Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people's lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium Plasma Technology, Apyx is solely focused on bringing transformative solutions to the physicians and patients it serves. The company's Helium Plasma Technology is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market.

Apyx Medical Corporation (APYX) CEO Charles Goodwin on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha 08-14-22

Apyx Medical GAAP EPS of -$0.16 beats by $0.03, revenue of $10.3M misses by $0.26M
Seeking Alpha 08-11-22

The Apyx Medical Corporation (NASDAQ: APYX) Metrics You Need To Know Right Now
Stocks Register 08-06-22

FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 to Contact the Firm
PR Newswire 08-05-22

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 to Contact the Firm
Business Wire 08-04-22